Scientists to expose most deadly infectious diseases in 3-D
October 31, 2007
These simplified images from Wayne Anderson's lab show how the polypeptide backbone of a Bacillus anthracis protein folds and curls around itself like a ribbon. It is one of 5,617 proteins in the bacteria that cause anthrax. Credit: Wayne Anderson
A scientist slides on a pair of plastic 3-D glasses and an unearthly blue multi-armed creature -- an image right out of a sci-fi horror flick -- seems to leap out of the computer screen into the laboratory.
But this is no movie director's fantasy. The horror image is real.
The eerie "creature" is from the deadly anthrax bacteria -- specifically one of its proteins. Scientists at Northwestern University's Feinberg School of Medicine are mapping parts of the lethal bacteria in three dimensions, exposing a new and intimate chemical portrait of the biological killer down to its very atoms. This view of the disease will offer scientists who design drugs a fresh opening into the bacteria’s vulnerabilities, and thus enable them to create drugs to disable it or vaccines to prevent it.
Anthrax is just the beginning. The Feinberg School is directing an ambitious national project that will map a rogues' gallery of 375 proteins from deadly infectious diseases over the next five years. It is being funded by a $31 million contract from the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health. The payoff could be a wave of new medicines to wipe out some of the worst scourges to ever infect the human race.
"The concept is fairly simple," said Wayne Anderson, who is leading the national project at the Feinberg School's new Center for Structural Genomics of Infectious Diseases. "If you have a lock and a key and you don't know what either one looks like, how will you design them to fit together"" The lock is Anderson's metaphor for the disease; the key is the drug or vaccine that will slip inside its atomic structure and destroy it.
To figure out where to throw the chemical equivalent of a monkey wrench into the anthrax cell -- and others --Anderson will be mapping key proteins the bacteria uses to do its work.
"We'll see what the proteins look like and see what they need to grow so scientists can use this information to design drugs to knock them out," explained Anderson, a professor of molecular pharmacology and biological chemistry. “We might look at a protein that copies a virus' or bacteria’s genome so it can infect people. If we can find a chemical to stop it from working, it prevents the virus from reproducing and spreading infection.”
The proteins in his lab, by the way, are not capable of triggering an infectious disease. "You need the actual virus or bacteria for that," Anderson said.
Eventually Anderson's gallery will be filled with the not-so-pretty genetic portraits of proteins from the plague, cholera, rabies, West Nile virus, viral encephalitis and Ebola, just to name a few. He'll also be looking at newly emerging diseases and drug resistant infections. His team -- which includes researchers at seven other institutions -- will churn out the three dimensional atomic structures of at least 75 disease proteins a year and quickly post their discoveries on a special website for scientists who can immediately use the information to work on new drugs.
This mega-assault on these diseases at such dizzying speed, scientifically speaking, represents a tectonic shift in how researchers are attacking infectious diseases.
Up until now, molecular pharmacologists -- the people who design new medicines -- had to work at a much slower pace because they had access to only one protein image from a disease at a time.
New state-of-the art technology has accelerated the process. "Now we are going through the genome and finding 100 proteins from a bacteria," explained Anderson. "We're looking at all of these and providing the information so scientists can look at more than one at a time."
To obtain these unusual proteins for their "photo op," Anderson first has to grow them into crystals. A few steps from his office is the “nursery,” where hundreds of thousands of viral and bacterial protein crystals grow in what resemble miniature ice-cube trays. The trays are stacked in giant incubators to keep the proteins at their favorite temperature.
Because Anderson is never sure what environment will produce a crystal -- some proteins prefer more acidity or salt than others, he tries hundreds of different recipes for each one.
Viewing these proteins down to the arrangement of their atoms requires an intense x-ray beam. One of the few sites in the country with this technology is the enormous Synchrotron at Argonne National Laboratory. From the air, the Synchrotron looks like an indoor track. And, in a way, it is. The only runners, however, are electrons circling the Synchrotron, which is actually a 40-sided polygon one kilometer around. As the electrons race around the polygon, they shoot off intense x-ray beams.
Working with equipment inside a special lead-walled station to protect them from radiation, scientists place a protein crystal -- just 1/10 of a millimeter -- into the Synchrotron x-ray beam. As the x-rays scatter off the crystal, the diffraction pattern reveals the location of the protein's electrons and atoms, a process called x-ray crystallography.
In early November, the university will launch a website, http://www.csgid.org, for scientists who specialize in different bacteria or viruses, so they can scan the project's list of infectious diseases and suggest which proteins Anderson and his colleagues should examine. “We hope we’ll get suggestions from people in the scientific community," said Anderson, who also is co-director of Northwestern's Synchrotron Research Center. "Their knowledge can be a big help to us because each bacteria makes thousands of proteins." The website also will be continuously updated to show scientists newly mapped proteins.
"We hope our effort will lay the groundwork for new drugs to treat or prevent some of the worst infectious diseases to plague our country and the world," Anderson said.
Source: Northwestern University
-
SUMO-snipping protein plays crucial role in T and B cell development
Jan 27, 2012 |
5 / 5 (3) |
0
-
Blood vessel mapping reveals four new 'ZIP codes'
Oct 24, 2011 |
3.7 / 5 (3) |
0
-
Reversing aging
Oct 17, 2011 |
4 / 5 (1) |
0
-
Novel technique uses RNA interference to block inflammation
Oct 09, 2011 |
5 / 5 (7) |
0
-
Structural Genomics Project creates blueprint for infectious disease and biodefense research
Sep 01, 2011 |
not rated yet |
0
-
Fast photon control brings quantum photonic technologies closer
9 hours ago |
5 / 5 (4) |
0
-
Engineers build first sub-10-nm carbon nanotube transistor
Feb 01, 2012 |
4.9 / 5 (33) |
30
-
Something old, something new: Evolution and the structural divergence of duplicate genes
Jan 31, 2012 |
4.6 / 5 (7) |
1
-
The hidden nanoworld of ice crystals: Revealing the dynamic behavior of quasi-liquid layers
Jan 30, 2012 |
5 / 5 (5) |
1
-
Stock market network reveals investor clustering
Jan 27, 2012 |
3.9 / 5 (23) |
8
More news stories
Plants use circadian rhythms to prepare for battle with insects
In a study of the molecular underpinnings of plants' pest resistance, Rice University biologists have shown that plants both anticipate daytime raids by hungry insects and make sophisticated preparations to ...
1 hour ago |
5 / 5 (2) |
0
|
Study finds fish of Antarctica threatened by climate change
A Yale-led study of the evolutionary history of Antarctic fish and their "anti-freeze" proteins illustrates how tens of millions of years ago a lineage of fish adapted to newly formed polar conditions ...
3 hours ago |
5 / 5 (2) |
0
|
Explosive evolution need not follow mass extinctions, says study of ancient zooplankton
Following one of Earth's five greatest mass extinctions, tiny marine organisms called graptoloids did not begin to rapidly develop new physical traits until about 2 million years after competing species became ...
3 hours ago |
5 / 5 (1) |
1
|
Writing a new code for life?
On "Star Trek, the aliens often look so human that crew members fall in love with them. But in real life, scientists in the field known as astrobiology can't be sure alien life would even be carbon-based like us, or use DNA ...
6 hours ago |
5 / 5 (5) |
1
Lens produces hours of scientific work in seconds
A new form of microscope which can produce results in seconds rather than hours dramatically speeding up the process of drug development - is being developed by researchers at the University of Strathclyde ...
7 hours ago |
4.3 / 5 (6) |
1
|
First-of-its-kind stem cell study re-grows healthy heart muscle in heart attack patients
Results from a Cedars-Sinai Heart Institute clinical trial show that treating heart attack patients with an infusion of their own heart-derived cells helps damaged hearts re-grow healthy muscle.
Sensing self and non-self: New research into immune tolerance
At the most basic level, the immune system must distinguish self from non-self, that is, it must discriminate between the molecular signatures of invading pathogens (non-self antigens) and cellular constituents that usually ...
Missing dark matter located: Intergalactic space is filled with dark matter
Researchers at the University of Tokyos Institute for the Physics and Mathematics of the Universe (IPMU) and Nagoya University used large-scale computer simulations and recent observational data of gravitational ...
Scientists discover reason for Mt. Hood's non-explosive nature
(PhysOrg.com) -- For a half-million years, Mount Hood has towered over the landscape, but unlike some of its cousins in Oregons Cascade Mountains and many other volcanoes around the Pacific Rim ...
Smoking bans lead to less, not more, smoking at home: study
Smoking bans in public/workplaces don't drive smokers to light up more at home, suggests a study of four European countries with smoke free legislation, published online in Tobacco Control.
Radiation treatment transforms breast cancer cells into cancer stem cells
Breast cancer stem cells are thought to be the sole source of tumor recurrence and are known to be resistant to radiation therapy and don't respond well to chemotherapy.